World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
10431
World Ranking
4753
National Ranking
2136

Howard M. Lederman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Howard M. Lederman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 153 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Howard M. Lederman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Howard M. Lederman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Howard M. Lederman is affiliated with Johns Hopkins University in the United States. Their research spans multiple fields with a strong focus on biochemistry, genetics, molecular biology, and medicine. Within these broad areas, Lederman's work specializes in molecular biology, immunology, cancer research, pulmonary and respiratory medicine, and infectious diseases.

The primary scientific topics addressed in Lederman's research include DNA repair mechanisms, carcinogens and genotoxicity assessment, immunodeficiency and autoimmune disorders, genetic neurodegenerative diseases, radiation therapy and dosimetry, as well as SARS-CoV-2 and COVID-19 research. This range reflects a multidisciplinary approach to understanding disease mechanisms at genetic and molecular levels, particularly related to immune function and genetic disorders.

Lederman has contributed to several peer-reviewed papers in notable journals, including the following recent publications:

  • "DNA methylation and gene expression signatures are associated with ataxia-telangiectasia phenotype," 2020, Scientific Reports
  • "Multidisciplinary Management of Ataxia Telangiectasia: Current Perspectives," 2021, Journal of Multidisciplinary Healthcare
  • "Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients," 2022, Open Forum Infectious Diseases
  • "Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk children," 2021, JCI Insight
  • "Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial," 2024, The Lancet Neurology

Frequent collaborators include Sharon A. McGrath-Morrow, Jennifer Wright, Valerie Natale, Cynthia Rothblum-Oviatt, and Thomas O. Crawford. These professional associations highlight ongoing partnerships in the fields of immunology and clinical research related to rare diseases and genetic disorders.

Lederman publishes regularly in several specialized journals with repeated contributions to the Journal of Allergy and Clinical Immunology, Orphanet Journal of Rare Diseases, Clinical Immunology, Journal of Clinical Immunology, and Research Square. This indicates a consistent engagement with communities focused on immunology, rare disease research, and clinical applications.

Best Publications

  • JM2, encoding a fork head–related protein, is mutated in X-linked autoimmunity–allergic disregulation syndrome

    Talal A. Chatila;Frank Blaeser;Nga Ho;Howard M. Lederman

  • Ataxia telangiectasia: a review

    Cynthia Rothblum-Oviatt;Jennifer Wright;Maureen A. Lefton-Greif;Sharon A. McGrath-Morrow

  • X-linked agammaglobulinemia: report on a United States registry of 201 patients.

    Jerry A. Winkelstein;Mary C. Marino;Howard M. Lederman;Stacie M. Jones

  • X-linked agammaglobulinemia: an analysis of 96 patients.

    Howard M. Lederman;Jerry A. Winkelstein

  • An essential role for BLNK in human B cell development.

    Yoshiyuki Minegishi;Jurg Rohrer;Elaine Coustan-Smith;Howard M. Lederman

  • Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1

    Raphael P. Viscidi;Kumudini Mayur;Howard M. Lederman;Alan D. Frankel

  • Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review.

    Jason A. Daniels;Howard M. Lederman;Anirban Maitra;Elizabeth A. Montgomery

  • Immunodeficiency and infections in ataxia-telangiectasia.

    Anna Nowak-Wegrzyn;Thomas O Crawford;Jerry A Winkelstein;Kathryn A Carson

  • Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature.

    Mary Beth Fasano;Kathleen E. Sullivan;Kathleen E. Sullivan;Sampson B. Sarpong;Sampson B. Sarpong;Robert A. Wood

  • Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen

    Hernan Valdez;Kimberly Y. Smith;Alan Landay;Elizabeth Connick

  • Overview of Infections in the Immunocompromised Host.

    Lesia K. Dropulic;Howard M. Lederman

  • Increased susceptibility to mycoplasma infection in patients with hypogammaglobulinemia

    Chaim M. Roifman;C. Pandu Rao;Howard M. Lederman;Sasson Lavi

  • Survival probability in ataxia telangiectasia

    Thomas O. Crawford;R. L. Skolasky;R. Fernandez;K. J. Rosquist

  • Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts

    William T. Shearer;Thomas A. Fleisher;Rebecca H. Buckley;Zuhair Ballas

  • Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency.

    Mary E. Bollinger;Francisco X. Arredondo-Vega;Ines Santisteban;Kathleen Schwarz

  • Adenosine Deaminase Deficiency in Adults

    Hulya Ozsahin;Francisco X. Arredondo-Vega;Ines Santisteban;Hanspeter Fuhrer

  • Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 among infants with sickle cell disease

    Katherine L. O'Brien;Andrea J. Swift;Jerry A. Winkelstein;Mathuram Santosham

  • Ataxia-telangiectasia (A-T): An emerging dimension of premature ageing.

    Yosef Shiloh;Howard M. Lederman

  • Incomplete Immune Reconstitution after Initiation of Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Patients with Severe CD4+ Cell Depletion

    Howard M. Lederman;Paige L. Williams;Julia W. Wu;Thomas G. Evans

  • Cryptosporidiosis Stimulates an Inflammatory Intestinal Response in Malnourished Haitian Children

    Beth D. Kirkpatrick;Michelle M. Daniels;Simone Sonia Jean;Jean W. Pape

Frequent Co-Authors

Jerry A. Winkelstein
Jerry A. Winkelstein Johns Hopkins University School of Medicine
Anna Nowak-Wegrzyn
Anna Nowak-Wegrzyn New York University
Kathleen E. Sullivan
Kathleen E. Sullivan Children's Hospital of Philadelphia
Paige L. Williams
Paige L. Williams Harvard University
Bradley A. Warady
Bradley A. Warady Children's Mercy Hospital
Michael S. Hershfield
Michael S. Hershfield Duke University
J. Allen McCutchan
J. Allen McCutchan University of California, San Diego
Judith S. Currier
Judith S. Currier University of California, Los Angeles
Diane R. Gold
Diane R. Gold Harvard University
Mary Ellen Conley
Mary Ellen Conley Rockefeller University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career opportunities in healthcare and research. Transitioning roles within nursing, such as moving from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (NP), offers specialization options for professionals aiming to deepen their clinical skills. Resources on how to transition from fnp to acute care np provide valuable guidance for this pathway.

Accelerated nursing programs are particularly popular among students who hold degrees in other fields but want to enter nursing quickly. Several reputable accelerated options exist, including the highly recommended accelerated fnp programs designed for swift advancement to nurse practitioner roles.

Additionally, individuals without prior nursing experience can explore online accelerated nursing programs for non nurses, which allow them to gain necessary credentials efficiently while balancing other commitments.

For those seeking a less competitive entry into nursing education, some of the easiest accelerated nursing programs provide accessible pathways without compromising quality. These programs can be strategic stepping stones toward careers that intersect with immunology research and clinical practice.

Best Scientists Citing Howard M. Lederman

Trending Scientists

Recently Published Articles